March 5, 2001
Health
Brand-name and generic drug makers are squaring off for a costly political battle — and consumers may pick up the tab.
Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.
We Recommend
Latest
view comments